高强度聚焦超声治疗原发性肝癌的进展
Advances of High-Intensity Focused Ultrasound Ablation in the Treatment of Primary Liver Cancer
DOI: 10.12677/ACM.2023.133460, PDF,   
作者: 郭蕊雨, 金成兵:重庆医科大学附属第二医院肿瘤中心,重庆
关键词: 高强度聚焦超声肝癌治疗High-Intensity Focused Ultrasound Liver Neoplasms Therapeutics
摘要: 原发性肝癌是最常见的恶性肿瘤之一,发病率高、预后差,其早期临床症状不典型,多数患者确诊时已是不可手术切除的中晚期。对于中晚期肝癌的主要局部治疗手段有肝动脉化疗栓塞、放疗、经皮肝穿刺肿瘤无水酒精注射等。近年来,一种新兴的局部微创治疗方法——高强度聚焦超声在肝癌临床治疗中已逐渐应用。本文就高强度聚焦超声在肝癌综合治疗中的应用进展进行综述,以利于为肝癌患者提供一种可选择的治疗方法。
Abstract: Primary liver cancer is one of the most common malignant tumors with high incidence and poor prognosis. Due to the atypical clinical symptoms in the early stage, most patients are diagnosed at advanced stage. At present, the main therapeutic methods for advanced primary liver cancer in-clude transcatheter arterial chemoembolization (TACE), radiotherapy, percutaneous ethanol intra-tumoral injection, etc. As an emerging mininally invasive technique, high-intensity focused ultra-sound (HIFU) ablation has been extensively used in the treatment of primary liver cancer clinically. We reviewed the progress of HIFU in the treatment of primary liver cancer in this article, in order to provide an alternative treatment for patients with primary liver cancer.
文章引用:郭蕊雨, 金成兵. 高强度聚焦超声治疗原发性肝癌的进展[J]. 临床医学进展, 2023, 13(3): 3234-3240. https://doi.org/10.12677/ACM.2023.133460

参考文献

[1] Llovet, J.M., de Baere, T., Kulik, L., et al. (2021) Locoregional Therapies in the Era of Molecular and Immune Treat-ments for Hepatocellular Carcinoma. Nature Reviews Gastroenterology & Hepatology, 18, 293-313. [Google Scholar] [CrossRef] [PubMed]
[2] Llovet, J.M., Kelley, R.K., Villanueva, A., et al. (2021) Hepato-cellular Carcinoma. Nature Reviews Disease Primers, 7, 6. [Google Scholar] [CrossRef] [PubMed]
[3] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortal-ity Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[4] Forner, A., Reig, M. and Bruix, J. (2018) Hepatocellular Carcinoma. The Lancet, 391, 1301-1314. [Google Scholar] [CrossRef
[5] Zhou, H. and Song, T. (2021) Conversion Therapy and Maintenance Therapy for Primary Hepatocellular Carcinoma. BioScience Trends, 15, 155-160. [Google Scholar] [CrossRef] [PubMed]
[6] Takeda, A., Sanuki, N., Tsurugai, Y., et al. (2016) Phase 2 Study of Stereotactic Body Radiotherapy and Optional Transarterial Chemoembolization for Solitary Hepatocellular Carcinoma Not Amenable to Resection and Radiofrequency Ablation. Cancer, 122, 2041-2049. [Google Scholar] [CrossRef] [PubMed]
[7] Siedek, F., Yeo, S.Y., Heijman, E., et al. (2019) Magnetic Reso-nance-Guided High-Intensity Focused Ultrasound (MR-HIFU): Technical Background and Overview of Current Clinical Applications (Part 1). Rofo, 191, 522-530. [Google Scholar] [CrossRef] [PubMed]
[8] Sehmbi, A.S., Froghi, S., Oliveira, D.A.M., et al. (2021) Systematic Re-view of the Role of High Intensity Focused Ultrasound (HIFU) in Treating Malignant Lesions of the Hepatobiliary Sys-tem. HPB (Oxford), 23, 187-196. [Google Scholar] [CrossRef] [PubMed]
[9] Cheung, T.T., Ma, K.W. and She, W.H. (2021) A Review on Ra-diofrequency, Microwave and High-Intensity Focused Ultrasound Ablations for Hepatocellular Carcinoma with Cirrhosis. The Hepatobiliary Surgery and Nutrition, 10, 193-209. [Google Scholar] [CrossRef] [PubMed]
[10] Tsang, S.H., Ma, K.W., She, W.H., et al. (2021) High-Intensity Focused Ultrasound Ablation of Liver Tumors in Difficult Locations. International Journal of Hyperthermia, 38, 56-64. [Google Scholar] [CrossRef] [PubMed]
[11] Prachee, I., Wu, F. and Cranston, D. (2021) Oxford’s Clinical Experience in the Development of High Intensity Focused Ultra-sound Therapy. International Journal of Hyperthermia, 38, 81-88. [Google Scholar] [CrossRef] [PubMed]
[12] Tempany, C.M., Mcdannold, N.J., Hynynen, K., et al. (2011) Focused Ultrasound Surgery in Oncology: Overview and Principles. Radiology, 259, 39-56. [Google Scholar] [CrossRef] [PubMed]
[13] Yamada, S., Takai, Y., Nemoto, K., et al. (1992) Intraoperative Radi-ation Therapy Combined with Hyperthermia against Pancreatic Carcinoma. The Tohoku Journal of Experimental Medi-cine, 166, 395-401. [Google Scholar] [CrossRef] [PubMed]
[14] Tang, H., Guo, Y., Peng, L., et al. (2018) In Vivo Targeted, Responsive, and Synergistic Cancer Nanotheranostics by Magnetic Resonance Imaging-Guided Synergistic High-Intensity Focused Ultrasound Ablation and Chemotherapy. ACS Applied Materials & Interfaces, 10, 15428-15441. [Google Scholar] [CrossRef] [PubMed]
[15] Izadifar, Z., Izadifar, Z., Chapman, D., et al. (2020) An Introduction to High Intensity Focused Ultrasound: Systematic Review on Principles, Devices, and Clinical Applications. Journal of Clinical Medicine, 9, 460. [Google Scholar] [CrossRef] [PubMed]
[16] Lee, K.W. (2021) The Asian Perspective on HIFU. International Journal of Hyperthermia, 38, 5-8. [Google Scholar] [CrossRef] [PubMed]
[17] Duc, N.M. and Keserci, B. (2019) Emerging Clinical Appli-cations of High-Intensity Focused Ultrasound. Diagnostic and Interventional Radiology, 25, 398-409. [Google Scholar] [CrossRef] [PubMed]
[18] Elhelf, I., Albahar, H., Shah, U., et al. (2018) High Intensity Focused Ultrasound: The Fundamentals, Clinical Applications and Research Trends. Diagnostic and Interventional Imaging, 99, 349-359. [Google Scholar] [CrossRef] [PubMed]
[19] Kennedy, J.E., Ter Haar, G.R. and Cranston, D. (2003) High Inten-sity Focused Ultrasound: Surgery of the Future? The British Journal of Radiology, 76, 590-599. [Google Scholar] [CrossRef] [PubMed]
[20] Hynynen, K., Chung, A.H., Colucci, V., et al. (1996) Potential Adverse Effects of High-Intensity Focused Ultrasound exposure on Blood Vessels in Vivo. Ultrasound in Medicine & Biology, 22, 193-201. [Google Scholar] [CrossRef] [PubMed]
[21] Forner, A., Reig, M.E., de Lope, C.R., et al. (2010) Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects. Seminars in Liver Disease, 30, 61-74. [Google Scholar] [CrossRef] [PubMed]
[22] Llovet, J.M. and Lencioni, R. (2020) mRECIST for HCC: Perfor-mance and Novel Refinements. Journal of Hepatology, 72, 288-306. [Google Scholar] [CrossRef] [PubMed]
[23] Fukuda, H., Ito, R., Ohto, M., et al. (2011) Treatment of Small Hepatocellular Carcinomas with US-Guided High-Intensity Focused Ultrasound. Ultrasound in Medicine & Biology, 37, 1222-1229. [Google Scholar] [CrossRef] [PubMed]
[24] Cheung, T.T., Fan, S.T., Chu, F.S., et al. (2013) Survival Analysis of High-Intensity Focused Ultrasound Ablation in Patients with Small Hepatocellular Carcinoma. HPB (Oxford), 15, 567-573. [Google Scholar] [CrossRef] [PubMed]
[25] Raoul, J.L., Forner, A., Bolondi, L., et al. (2019) Updated Use of TACE for Hepatocellular Carcinoma Treatment: How and When to Use It Based on Clinical Evidence. Cancer Treatment Reviews, 72, 28-36. [Google Scholar] [CrossRef] [PubMed]
[26] Sergio, A., Cristofori, C., Cardin, R., et al. (2008) Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness. The American Journal of Gastroenterology, 103, 914-921. [Google Scholar] [CrossRef] [PubMed]
[27] Forner, A. and Trinchet, J.C. (2009) Transarterial Therapies in HCC: Does Embolization Increase Survival? Journal of Hepatology, 51, 981-983. [Google Scholar] [CrossRef] [PubMed]
[28] Gu, L., Shen, Z., Ji, L., et al. (2022) High-Intensity Focused Ul-trasound Alone or Combined with Transcatheter Arterial Chemoembolization for the Treatment of Hepatocellular Carci-noma with Unsuitable Indications for Hepatectomy and Radiofrequency Ablation: A Phase II Clinical Trial. Surgical Endoscopy, 36, 1857-1867. [Google Scholar] [CrossRef] [PubMed]
[29] Li, C., Zhang, W., Zhang, R., et al. (2010) Therapeutic Effects and Prognostic Factors in High-Intensity Focused Ultrasound Combined with Chemoembolisation for Larger Hepatocel-lular Carcinoma. European Journal of Cancer, 46, 2513-2521. [Google Scholar] [CrossRef] [PubMed]
[30] Sun, M., Shang, P., Bai, J., et al. (2021) High-Intensity Focused Ultrasound Ablation Combined with Transcatheter Arterial Chemoembolization Improves Long-Term Efficacy and Prognosis of Primary Liver Cancer. Journal of Clinical Labora-tory Analysis, 35, e23633. [Google Scholar] [CrossRef] [PubMed]
[31] Keane, F.K. and Hong, T.S. (2017) Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer. Cancer Control, 24, 1-12. [Google Scholar] [CrossRef] [PubMed]
[32] Feng, M. and Ben-Josef, E. (2011) Radiation Therapy for Hepa-tocellular Carcinoma. Seminars in Radiation Oncology, 21, 271-277. [Google Scholar] [CrossRef] [PubMed]
[33] Chen, L.C., Lin, H.Y., Hung, S.K., et al. (2021) Role of Modern Radiotherapy in Managing Patients with Hepatocellular Carcinoma. World Journal of Gastroenterology, 27, 2434-2457. [Google Scholar] [CrossRef] [PubMed]
[34] Jin, C., Yang, W., Ran, L., et al. (2020) Feasibility of High-Intensity Focused Ultrasound for Hepatocellular Carcinoma after Stereotactic Body Radiation Therapy: Initial Expe-rience. Ultrasound in Medicine & Biology, 46, 2744-2751. [Google Scholar] [CrossRef] [PubMed]
[35] Wang, L., Li, L., Wang, X., et al. (2018) Comparison of Combination Stereotactic Body Radiotherapy plus High-Intensity Focused Ultrasound Ablation versus Stereotactic Body Radiotherapy Alone for Massive Hepatocellular Carcinoma. Medical Science Monitor, 24, 8298-8305. [Google Scholar] [CrossRef
[36] Wu, F., Chen, W.Z., Bai, J., et al. (2002) Tumor Vessel Destruction Resulting from High-Intensity Focused Ultrasound in Patients with Solid Malignancies. Ultrasound in Medicine & Biol-ogy, 28, 535-542. [Google Scholar] [CrossRef
[37] Zhou, J., Sun, H., Wang, Z., et al. (2020) Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer, 9, 682-720. [Google Scholar] [CrossRef] [PubMed]
[38] Qiao, W., Yu, Y., Huang, Y., et al. (2020) Impact of Focused Ultrasound on the Ethanol Ablation of VX2 Liver Tumours in Rabbits. European Radiology, 30, 5862-5870. [Google Scholar] [CrossRef] [PubMed]
[39] 谭新劲, 陈健, 林瑞禄, 等. 高强度聚焦超声联合经皮穿刺注射无水乙醇治疗原发性肝癌[J]. 西南国防医药, 2006, 16(5): 517-519.
[40] Moore, W.E., Lopez, R.M., Matthews, D.E., et al. (1989) Evaluation of High-Intensity Therapeutic Ultrasound Irradiation in the Treatment of Experimental He-patoma. Journal of Pediatric Surgery, 24, 30-33. [Google Scholar] [CrossRef
[41] Zhang, T., Chen, L., Zhang, S., et al. (2017) Effects of High-Intensity Focused Ultrasound on Cisplatin-Resistant Human Lung Adenocarcinoma in Vitro and in Vivo. Acta Biochimica et Biophysica Sinica (Shanghai), 49, 1092-1098. [Google Scholar] [CrossRef] [PubMed]
[42] Li, T., Wang, Y.N., Khokhlova, T.D., et al. (2015) Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer. Cancer Research, 75, 3738-3746. [Google Scholar] [CrossRef
[43] 付斯瑜, 徐涛, 郭智荣, 等. 高强度聚焦超声配合FOLFOX4方案治疗晚期肝癌的临床观察[J]. 医学与哲学(临床决策论坛版), 2010, 31(2): 24-25.
[44] 陈忠民, 徐广伟, 任林广, 等. 热疗与化疗联合作用Hep-A-22荷瘤小鼠的实验观察[J]. 实用肿瘤学杂志, 2001, 15(1): 4-5.